BFEC
KRTX

Benjamin F. Edwards & Company’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$1K – 2290
2023
Q4 		$1K Buy
+2
New +$389 ﹤0.01% 2074

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Benjamin F. Edwards & Company's KRTX Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Benjamin F. Edwards & Company reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 2 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's Karuna Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.